Benzinga Psychedelics Capital Conference

Are Psychedelics Cannabis 2.0? Takeaways From The Top Psychedelics Business Conference In The US
EXCLUSIVE: MDMA Therapy Experts Debate Upcoming Approval And Psychedelic Market Opps
Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More
EXCLUSIVE: MDMA Therapy Experts Debate Upcoming Approval And Psychedelic Market Opps
Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More
EXCLUSIVE: Ketamine Therapy Leaders Share Bold Vision For Future At Benzinga's Psychedelics Capital Conference
EXCLUSIVE: In Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key'

Benzinga Psychedelics Capital Conference Recent News

EXCLUSIVE: Investing In The Unique Growth Market Of Psychedelics
The global psychedelics market of drugs such as psilocybin, ketamine and LSD is booming and there are plenty of ways to get involved in the space.
Psyched: MDMA Therapy Advances With FDA, Alternatives For Alcohol Addiction, Prince Harry In The Spotlight And More
MDMA Therapy For PTSD Nearing Legalization In U.S. And Worldwide, MAPS Releases Promising Data
Revolutionizing Psychedelics: 2 Industry Leaders Collaborate To Offer Clinical-Grade MDMA Capsules
MDXX-class molecules producer PharmAla Biotech Holdings Inc.
Are Next-Gen Psychedelics The Incoming Solution For Mental Health? Learn It All At Benzinga's Psychedelics Capital Conference
Since the beginning of the new wave in medicine and public opinion, there has been a retaking of psychedelics-assisted therapy for the treatment of mental health conditions commonly known as Psychedelics Renaiss
This Psychiatrist Says Cannabis Is A Minor-League Psychedelic & Undervalued Investment Opportunity
Cannabis is a psychedelic that belongs to the group of mind-manifesting substances, according to Dr. Julie Holland. "When you get high on cannabis, you can see your thoughts differently, and it can give you a bigger perspective on life," she said in an interview with Rena Sherbill from the Cannabis Investing Podcast.
Psyched: Canada's Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism A patient-led lawsuit against the Canadian government is claiming access to therapeutic psilocybin is a constitutional right under the Canadian Charter of Rights and Freedoms.
Are Psychedelics A Threat To Alcohol And Tobacco Industries? A Glance At Thriving Advances
As the attachment to both tobacco and alcohol is deeply rooted and likely intertwined with other human and societal factors, it is evident these behaviors are complex to analyze.  And yet, the near future seems to hold hope for those ready and willing to disengage from these practices. The formula would include patience, support and psychedelics.
What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry
The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey.
High-Profile Highs: How Celebrity Advocacy Is Transforming Society's Views On Psychedelics And Cannabis
As part of the recent so-called “psychedelics renaissance,” numerous celebrities, global 
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial
Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event
The Benzinga Psychedelics Capital Conference (PCC) is rapidly becoming the place to be for all those interested or involved in the space. In addition to being the place where deals are done, you'll have the opportunity to meet, connect with and learn from some of the most knowledgeable people in the ever-expanding world of psychedelics.
Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person
This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved in the space, will take place on April 13, following our established Cannabis Capital Confere
Benzinga's Psychedelics Capital Conference: Meet An Unrivaled Group Of Advisors And Fund Partners
The upcoming Psychedelics Capital Conference constitutes Benzinga’s effort to provide an exclusive opportunity to meet, connect with and learn from some of the most knowledgeable people in the space. 
Benzinga's Psychedelics Capital Conference Is Open For Business: Meet Our Renowned Keynote Speaker
This year is the second edition of what is rapidly becoming the place to be for those interested in or already involved in the psychedelics space: new deals get closed, money gets raised and knowledge is shared at this not-to-be-missed gathering for investors, key partners as well as the general public. 
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.  
Algernon Pharmaceuticals Goes 4:1 In Forward Share Split After Announcing New TBI Program
Canadian clinical-stage psychedelics developer Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) will start trading its Class A common shares following a 4-to-1 stock split towards increasing liquidity. 
Women's Footprint In Psychedelics Is Undeniable, Benzinga's Psychedelics Advisory Council's Six New Trailblazers
In its capacity as a financial news and media outlet, Benzinga has added six new members to its Psychedelics Advisory Council.
World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them
The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business landscape.
What Scaling Looks Like In The Cannabis Context
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Sponsored
The Company Driving Consumer Cannabis Access Across Global Markets
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Vahan Ajamian, CPA, CA, CFA and Capital Markets Advisor at High Tide Inc. (NASDAQ: HIDI) was a guest speaker at Benzinga’s Cannabis Capital Conference on April 21, 2022. 
Sponsored
Making Sure You Have The Right Equipment
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nenad Yashruti, Business Development Director at Root Sciences, was a guest speaker at Benzinga's Cannabis Capital Conference on April 20, 2022.
Sponsored
PsyBio Therapeutics Presents "How Genetically Modified Bacteria Can Yield Best-In-Class Psychedelics" At The Psychedelic Capital Conference
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Sponsored
Filament Health Talks Psilocybin, Psilocin And How Natural Psychedelics Could Conquer The Market
Filament Health (OTCQB: FLHLF) (NEO:FH) is a clinical-stage psychedelic drug development company creating safe, standardized, naturally-derived psychedelic medicines. 
Sponsored